BUPAIZER
Effective
CONTROL OF
TICK-BORNE
PROTOZOAL
DISEASES
Targeted Buparvaquone 50 mg injection for the treatment of theileriosis
Who We Are
Maizer is a veterinary and agricultural health company based in France, dedicated to science-backed solutions for animal health and productivity. Our medicines are developed to High quality standards, combining efficacy, safety and practical farm use.
Veterinary expertise – Formulations designed specifically for livestock and companion animals.
Quality first – Manufactured under strict quality control to ensure consistent therapeutic results.
Global support – Trusted by vets and distributors in multiple markets.
Why Choose BUPAIZER for Your Herd?
Bupaizer is trusted by veterinary professionals and livestock operators for the effective treatment of tick-borne protozoal diseases. Its Buparvaquone-based formulation provides dependable therapeutic results under field conditions.
Buparvaquone 50 mg specifically targets protozoal parasites responsible for theileriosis and related tick-borne diseases.
Provides strong therapeutic effect for pneumonia, enteritis, and mixed bacterial infections commonly seen in ruminants and farm animals.
Simple once-daily intramuscular injection makes it practical for field use in calves, goats, sheep, camels, and other livestock.
Take the Next Step in Protozoal Disease Control
Partner with Maizer to bring a proven Buparvaquone-based treatment to your market. Bupaizer supports veterinary professionals with reliable control of tick-borne protozoal infections.
